• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·REGN
Held by 3 Gurus
Share

Regeneron Pharmaceuticals, Inc. Stocks

$ 793.74Last Updated 14.09.2026

Issuer Rating

6/7
Performance

Favourable

Risk

Low

Recommendation

Buy

Market Cap

$ 80.51B

In Guru Portfolios

Bob Prince, Greg Jensen, Karen Karniol-Tambour

Portfolio Weight (%)

0.1%

Change

+0.05%

Fund

Bridgewater Associates

Kenneth Griffin

Portfolio Weight (%)

0.1%

Change

-0.01%

Fund

CITADEL ADVISORS LLC

Steven Cohen

Portfolio Weight (%)

0.0%

Change

-0.15%

Fund

Point72 Asset Management, L.P.

Manager
Fund
Portfolio Weight (%)
Change
Bob Prince, Greg Jensen, Karen Karniol-TambourBridgewater Associates0.1%+0.05%
Kenneth GriffinCITADEL ADVISORS LLC0.1%-0.01%
Steven CohenPoint72 Asset Management, L.P.0.0%-0.15%

Trending

15.09.2026 13:40

Anthropic's supplier has not revised its revenue forecasts due to a potential slowdown in the AI sector

15.09.2026 12:58

The government bond sell-off has spread beyond the U.S.: yields have surged in Asia and Europe

15.09.2026 12:06

BofA shares fell the most since April 2025. The market was spooked by the bank’s CEO’s remarks

15.09.2026 10:55

BlackRock recommended increasing the allocation to emerging-market stocks, despite the risks posed by AI

15.09.2026 10:35

Morning Highlights: 10-Year Treasury Yield Hits New High, OpenAI Acquires a Startup

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026